nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.0173	0.0173	CcSEcCtD
Nebivolol—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.0148	0.0148	CcSEcCtD
Nebivolol—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.0132	0.0132	CcSEcCtD
Nebivolol—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.0131	0.0131	CcSEcCtD
Nebivolol—Oedema peripheral—Progesterone—uterine cancer	0.0131	0.0131	CcSEcCtD
Nebivolol—Cardiac disorder—Progesterone—uterine cancer	0.0123	0.0123	CcSEcCtD
Nebivolol—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.0122	0.0122	CcSEcCtD
Nebivolol—Psoriasis—Epirubicin—uterine cancer	0.012	0.012	CcSEcCtD
Nebivolol—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.0118	0.0118	CcSEcCtD
Nebivolol—Mental disorder—Progesterone—uterine cancer	0.0116	0.0116	CcSEcCtD
Nebivolol—Malnutrition—Progesterone—uterine cancer	0.0115	0.0115	CcSEcCtD
Nebivolol—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.0112	0.0112	CcSEcCtD
Nebivolol—Psoriasis—Doxorubicin—uterine cancer	0.0111	0.0111	CcSEcCtD
Nebivolol—Angioedema—Progesterone—uterine cancer	0.0105	0.0105	CcSEcCtD
Nebivolol—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.0105	0.0105	CcSEcCtD
Nebivolol—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.0105	0.0105	CcSEcCtD
Nebivolol—Vertigo—Progesterone—uterine cancer	0.0104	0.0104	CcSEcCtD
Nebivolol—Syncope—Progesterone—uterine cancer	0.0104	0.0104	CcSEcCtD
Nebivolol—Loss of consciousness—Progesterone—uterine cancer	0.0101	0.0101	CcSEcCtD
Nebivolol—Chest pain—Progesterone—uterine cancer	0.00983	0.00983	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00976	0.00976	CcSEcCtD
Nebivolol—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00956	0.00956	CcSEcCtD
Nebivolol—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.0094	0.0094	CcSEcCtD
Nebivolol—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00938	0.00938	CcSEcCtD
Nebivolol—Shock—Progesterone—uterine cancer	0.00927	0.00927	CcSEcCtD
Nebivolol—Nervous system disorder—Progesterone—uterine cancer	0.00924	0.00924	CcSEcCtD
Nebivolol—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00919	0.00919	CcSEcCtD
Nebivolol—Skin disorder—Progesterone—uterine cancer	0.00915	0.00915	CcSEcCtD
Nebivolol—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.0089	0.0089	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00884	0.00884	CcSEcCtD
Nebivolol—Insomnia—Progesterone—uterine cancer	0.00852	0.00852	CcSEcCtD
Nebivolol—Paraesthesia—Progesterone—uterine cancer	0.00846	0.00846	CcSEcCtD
Nebivolol—Dyspnoea—Progesterone—uterine cancer	0.0084	0.0084	CcSEcCtD
Nebivolol—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0084	0.0084	CcSEcCtD
Nebivolol—Somnolence—Progesterone—uterine cancer	0.00837	0.00837	CcSEcCtD
Nebivolol—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00837	0.00837	CcSEcCtD
Nebivolol—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00836	0.00836	CcSEcCtD
Nebivolol—Bronchospasm—Etoposide—uterine cancer	0.00834	0.00834	CcSEcCtD
Nebivolol—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00829	0.00829	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Progesterone—uterine cancer	0.00813	0.00813	CcSEcCtD
Nebivolol—Fatigue—Progesterone—uterine cancer	0.00812	0.00812	CcSEcCtD
Nebivolol—Atrioventricular block—Epirubicin—uterine cancer	0.00781	0.00781	CcSEcCtD
Nebivolol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00772	0.00772	CcSEcCtD
Nebivolol—Gastrointestinal pain—Progesterone—uterine cancer	0.0077	0.0077	CcSEcCtD
Nebivolol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00767	0.00767	CcSEcCtD
Nebivolol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00761	0.00761	CcSEcCtD
Nebivolol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00759	0.00759	CcSEcCtD
Nebivolol—Urticaria—Progesterone—uterine cancer	0.00748	0.00748	CcSEcCtD
Nebivolol—Acute coronary syndrome—Etoposide—uterine cancer	0.00745	0.00745	CcSEcCtD
Nebivolol—Abdominal pain—Progesterone—uterine cancer	0.00745	0.00745	CcSEcCtD
Nebivolol—Myocardial infarction—Etoposide—uterine cancer	0.00741	0.00741	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00737	0.00737	CcSEcCtD
Nebivolol—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00736	0.00736	CcSEcCtD
Nebivolol—Atrioventricular block—Doxorubicin—uterine cancer	0.00722	0.00722	CcSEcCtD
Nebivolol—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00698	0.00698	CcSEcCtD
Nebivolol—Hypersensitivity—Progesterone—uterine cancer	0.00694	0.00694	CcSEcCtD
Nebivolol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00678	0.00678	CcSEcCtD
Nebivolol—Asthenia—Progesterone—uterine cancer	0.00676	0.00676	CcSEcCtD
Nebivolol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00675	0.00675	CcSEcCtD
Nebivolol—Pruritus—Progesterone—uterine cancer	0.00666	0.00666	CcSEcCtD
Nebivolol—Thrombocytopenia—Dactinomycin—uterine cancer	0.00652	0.00652	CcSEcCtD
Nebivolol—Diarrhoea—Progesterone—uterine cancer	0.00645	0.00645	CcSEcCtD
Nebivolol—Cardiac disorder—Etoposide—uterine cancer	0.0063	0.0063	CcSEcCtD
Nebivolol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00629	0.00629	CcSEcCtD
Nebivolol—Dizziness—Progesterone—uterine cancer	0.00623	0.00623	CcSEcCtD
Nebivolol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00612	0.00612	CcSEcCtD
Nebivolol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00604	0.00604	CcSEcCtD
Nebivolol—Vomiting—Progesterone—uterine cancer	0.00599	0.00599	CcSEcCtD
Nebivolol—Renal failure acute—Epirubicin—uterine cancer	0.00595	0.00595	CcSEcCtD
Nebivolol—Rash—Progesterone—uterine cancer	0.00594	0.00594	CcSEcCtD
Nebivolol—Dermatitis—Progesterone—uterine cancer	0.00593	0.00593	CcSEcCtD
Nebivolol—Headache—Progesterone—uterine cancer	0.0059	0.0059	CcSEcCtD
Nebivolol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00584	0.00584	CcSEcCtD
Nebivolol—Fatigue—Dactinomycin—uterine cancer	0.00574	0.00574	CcSEcCtD
Nebivolol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00564	0.00564	CcSEcCtD
Nebivolol—Nausea—Progesterone—uterine cancer	0.0056	0.0056	CcSEcCtD
Nebivolol—Renal failure acute—Doxorubicin—uterine cancer	0.00551	0.00551	CcSEcCtD
Nebivolol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00544	0.00544	CcSEcCtD
Nebivolol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00543	0.00543	CcSEcCtD
Nebivolol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00538	0.00538	CcSEcCtD
Nebivolol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00538	0.00538	CcSEcCtD
Nebivolol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00535	0.00535	CcSEcCtD
Nebivolol—Vertigo—Etoposide—uterine cancer	0.0053	0.0053	CcSEcCtD
Nebivolol—Abdominal pain—Dactinomycin—uterine cancer	0.00526	0.00526	CcSEcCtD
Nebivolol—Loss of consciousness—Etoposide—uterine cancer	0.00519	0.00519	CcSEcCtD
Nebivolol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00507	0.00507	CcSEcCtD
Nebivolol—Chest pain—Etoposide—uterine cancer	0.00503	0.00503	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00499	0.00499	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00495	0.00495	CcSEcCtD
Nebivolol—Hypersensitivity—Dactinomycin—uterine cancer	0.00491	0.00491	CcSEcCtD
Nebivolol—Asthenia—Dactinomycin—uterine cancer	0.00478	0.00478	CcSEcCtD
Nebivolol—Thrombocytopenia—Etoposide—uterine cancer	0.00472	0.00472	CcSEcCtD
Nebivolol—Skin disorder—Etoposide—uterine cancer	0.00468	0.00468	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00458	0.00458	CcSEcCtD
Nebivolol—Diarrhoea—Dactinomycin—uterine cancer	0.00456	0.00456	CcSEcCtD
Nebivolol—Paraesthesia—Etoposide—uterine cancer	0.00433	0.00433	CcSEcCtD
Nebivolol—Dyspnoea—Etoposide—uterine cancer	0.0043	0.0043	CcSEcCtD
Nebivolol—Somnolence—Etoposide—uterine cancer	0.00428	0.00428	CcSEcCtD
Nebivolol—Vomiting—Dactinomycin—uterine cancer	0.00423	0.00423	CcSEcCtD
Nebivolol—Rash—Dactinomycin—uterine cancer	0.0042	0.0042	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Etoposide—uterine cancer	0.00416	0.00416	CcSEcCtD
Nebivolol—Fatigue—Etoposide—uterine cancer	0.00415	0.00415	CcSEcCtD
Nebivolol—Nausea—Dactinomycin—uterine cancer	0.00395	0.00395	CcSEcCtD
Nebivolol—Gastrointestinal pain—Etoposide—uterine cancer	0.00394	0.00394	CcSEcCtD
Nebivolol—Bradycardia—Epirubicin—uterine cancer	0.00387	0.00387	CcSEcCtD
Nebivolol—Urticaria—Etoposide—uterine cancer	0.00383	0.00383	CcSEcCtD
Nebivolol—Abdominal pain—Etoposide—uterine cancer	0.00381	0.00381	CcSEcCtD
Nebivolol—Oedema peripheral—Epirubicin—uterine cancer	0.00375	0.00375	CcSEcCtD
Nebivolol—Bradycardia—Doxorubicin—uterine cancer	0.00358	0.00358	CcSEcCtD
Nebivolol—Hypersensitivity—Etoposide—uterine cancer	0.00355	0.00355	CcSEcCtD
Nebivolol—Cardiac disorder—Epirubicin—uterine cancer	0.00353	0.00353	CcSEcCtD
Nebivolol—Oedema peripheral—Doxorubicin—uterine cancer	0.00347	0.00347	CcSEcCtD
Nebivolol—Asthenia—Etoposide—uterine cancer	0.00346	0.00346	CcSEcCtD
Nebivolol—Pruritus—Etoposide—uterine cancer	0.00341	0.00341	CcSEcCtD
Nebivolol—Mental disorder—Epirubicin—uterine cancer	0.00333	0.00333	CcSEcCtD
Nebivolol—Malnutrition—Epirubicin—uterine cancer	0.00331	0.00331	CcSEcCtD
Nebivolol—Diarrhoea—Etoposide—uterine cancer	0.0033	0.0033	CcSEcCtD
Nebivolol—Cardiac disorder—Doxorubicin—uterine cancer	0.00326	0.00326	CcSEcCtD
Nebivolol—Dizziness—Etoposide—uterine cancer	0.00319	0.00319	CcSEcCtD
Nebivolol—Mental disorder—Doxorubicin—uterine cancer	0.00308	0.00308	CcSEcCtD
Nebivolol—Vomiting—Etoposide—uterine cancer	0.00306	0.00306	CcSEcCtD
Nebivolol—Malnutrition—Doxorubicin—uterine cancer	0.00306	0.00306	CcSEcCtD
Nebivolol—Rash—Etoposide—uterine cancer	0.00304	0.00304	CcSEcCtD
Nebivolol—Dermatitis—Etoposide—uterine cancer	0.00304	0.00304	CcSEcCtD
Nebivolol—Headache—Etoposide—uterine cancer	0.00302	0.00302	CcSEcCtD
Nebivolol—Vertigo—Epirubicin—uterine cancer	0.00297	0.00297	CcSEcCtD
Nebivolol—Syncope—Epirubicin—uterine cancer	0.00297	0.00297	CcSEcCtD
Nebivolol—Loss of consciousness—Epirubicin—uterine cancer	0.00291	0.00291	CcSEcCtD
Nebivolol—Nausea—Etoposide—uterine cancer	0.00286	0.00286	CcSEcCtD
Nebivolol—Chest pain—Epirubicin—uterine cancer	0.00282	0.00282	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.0028	0.0028	CcSEcCtD
Nebivolol—Vertigo—Doxorubicin—uterine cancer	0.00275	0.00275	CcSEcCtD
Nebivolol—Syncope—Doxorubicin—uterine cancer	0.00275	0.00275	CcSEcCtD
Nebivolol—Loss of consciousness—Doxorubicin—uterine cancer	0.00269	0.00269	CcSEcCtD
Nebivolol—Shock—Epirubicin—uterine cancer	0.00266	0.00266	CcSEcCtD
Nebivolol—Nervous system disorder—Epirubicin—uterine cancer	0.00265	0.00265	CcSEcCtD
Nebivolol—Thrombocytopenia—Epirubicin—uterine cancer	0.00264	0.00264	CcSEcCtD
Nebivolol—Skin disorder—Epirubicin—uterine cancer	0.00262	0.00262	CcSEcCtD
Nebivolol—Chest pain—Doxorubicin—uterine cancer	0.00261	0.00261	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00259	0.00259	CcSEcCtD
Nebivolol—Shock—Doxorubicin—uterine cancer	0.00246	0.00246	CcSEcCtD
Nebivolol—Nervous system disorder—Doxorubicin—uterine cancer	0.00245	0.00245	CcSEcCtD
Nebivolol—Thrombocytopenia—Doxorubicin—uterine cancer	0.00245	0.00245	CcSEcCtD
Nebivolol—Insomnia—Epirubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Nebivolol—Skin disorder—Doxorubicin—uterine cancer	0.00243	0.00243	CcSEcCtD
Nebivolol—Paraesthesia—Epirubicin—uterine cancer	0.00243	0.00243	CcSEcCtD
Nebivolol—Dyspnoea—Epirubicin—uterine cancer	0.00241	0.00241	CcSEcCtD
Nebivolol—Somnolence—Epirubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
Nebivolol—Fatigue—Epirubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
Nebivolol—Insomnia—Doxorubicin—uterine cancer	0.00226	0.00226	CcSEcCtD
Nebivolol—Paraesthesia—Doxorubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Nebivolol—Dyspnoea—Doxorubicin—uterine cancer	0.00223	0.00223	CcSEcCtD
Nebivolol—Somnolence—Doxorubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Nebivolol—Gastrointestinal pain—Epirubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00216	0.00216	CcSEcCtD
Nebivolol—Fatigue—Doxorubicin—uterine cancer	0.00215	0.00215	CcSEcCtD
Nebivolol—Urticaria—Epirubicin—uterine cancer	0.00215	0.00215	CcSEcCtD
Nebivolol—Abdominal pain—Epirubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Nebivolol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Nebivolol—Hypersensitivity—Epirubicin—uterine cancer	0.00199	0.00199	CcSEcCtD
Nebivolol—Urticaria—Doxorubicin—uterine cancer	0.00199	0.00199	CcSEcCtD
Nebivolol—Abdominal pain—Doxorubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Nebivolol—Asthenia—Epirubicin—uterine cancer	0.00194	0.00194	CcSEcCtD
Nebivolol—Pruritus—Epirubicin—uterine cancer	0.00191	0.00191	CcSEcCtD
Nebivolol—Diarrhoea—Epirubicin—uterine cancer	0.00185	0.00185	CcSEcCtD
Nebivolol—Hypersensitivity—Doxorubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Nebivolol—Asthenia—Doxorubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Nebivolol—Dizziness—Epirubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Nebivolol—Pruritus—Doxorubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Nebivolol—Vomiting—Epirubicin—uterine cancer	0.00172	0.00172	CcSEcCtD
Nebivolol—Diarrhoea—Doxorubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Nebivolol—Rash—Epirubicin—uterine cancer	0.0017	0.0017	CcSEcCtD
Nebivolol—Dermatitis—Epirubicin—uterine cancer	0.0017	0.0017	CcSEcCtD
Nebivolol—Headache—Epirubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Nebivolol—Dizziness—Doxorubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Nebivolol—Nausea—Epirubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Nebivolol—Vomiting—Doxorubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Nebivolol—Rash—Doxorubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Nebivolol—Dermatitis—Doxorubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Nebivolol—Headache—Doxorubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Nebivolol—Nausea—Doxorubicin—uterine cancer	0.00148	0.00148	CcSEcCtD
